Načítá se...
Does Natalizumab Induce or Aggravate Psoriasis? A Case Study and Review of the Literature
Psoriasis is a relatively common immune-mediated chronic inflammatory skin disease. It is well known that interferon-beta, a drug used in the management of relapsing-remitting multiple sclerosis, could exacerbate or induce de novo psoriasis. There is limited evidence in the literature based only on...
Uloženo v:
| Vydáno v: | Case Rep Neurol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
S. Karger AG
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6180259/ https://ncbi.nlm.nih.gov/pubmed/30323758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000492891 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|